ONESTX-01, a potent inhibitor of Steroid Sulphatase (STS), that restores neuron cholinergic activity and decreases cognitive impairment: design of a phase IIa clinical study
Year: 2024
Type: article
Authors: Andrés-Simón, V, Valle-Galisteo, J, Fernández-Cabrera, JA, Ramos-Pozo, A, Hernández-Curiel, JM, Gavaldá-Martín, S,, García Gutierrez, C, Sánchez Romero, I, Pérez-Jiménez, Mercedes M., Rodríguez Sandoval, E, Aires-Trapote, A, Muñoz Ruiz, Manuel Jesús, Carrión Rodríguez, Ángel Manuel, Cebolla Ramírez A
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Alzheimer's Association, American Heart Association, Alzheimer's Drug Discovery Foundation, Eli Lilly and Company, Biogen, BrightFocus Foundation, Foundation for Barnes-Jewish Hospital, Familjen Erling-Perssons Stiftelse, Cure Alzheimer's Fund, Stiftelsen för Gamla Tjänarinnor, Coins for Alzheimer's Research Trust, Prothena, CVS Health, Celltrion, Apellis Pharmaceuticals, Centene Corporation, Good Ventures Foundation, Alzheimer's Research Trust, National Institute for Health and Care Research, University College London, European Commission, Eisai, Hjärnfonden, Novo Nordisk, Vetenskapsrådet, Siemens Healthineers, IXICO, UK Dementia Research Institute, National Institutes of Health, Directorate for Biological Sciences, Genentech, Avid Radiopharmaceuticals, HORIZON EUROPE Framework Programme, National Institute on Aging, Co-creation place formation support program
Awards: G1057200632, G1343867371, G150733400, G1546555014, G1588116593, Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD), G1771944843, G1833008592, G1883972115, G1928552717, G201353144, G2081597990, G237833635, G2543812357, G2605446147, G292763017, Fluid biomarkers for neurodegenerative dementias, G3842727039, G3914690605, G4260843567, G432431387, G4377393254, G5040492720, Fluid biomarkers for neurodegenerative dementias, G5576250680, CASCADE: CAuSe or Consequence in Alzheimer DiseasE?, G6158734006, G6207287561, Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis, G6745400708, G691317373, G8782684654, Alzheimer's Clinical Trials Consortium (ACTC), NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course)
OpenAlex ID: W7199478074
